- Home
- ARE vs BMRN Comparison
ARE vs BMRN Comparison
Compare ARE & BMRN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ARE | BMRN |
|---|---|---|
| Founded | 1994 | 1996 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Real Estate Investment Trusts | Biotechnology: Pharmaceutical Preparations |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 8.8B | 10.0B |
| IPO Year | 1997 | 1999 |
Fundamental Metrics
Financial Performance| Metric | ARE | BMRN |
|---|---|---|
| Price | $49.14 | $59.27 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 10 | 19 |
| Target Price | $62.75 | ★ $89.74 |
| AVG Volume (30 Days) | ★ 3.3M | 3.0M |
| Earning Date | 01-26-2026 | 02-18-2026 |
| Dividend Yield | ★ 9.56% | N/A |
| EPS Growth | N/A | ★ 59.53 |
| EPS | N/A | ★ 2.68 |
| Revenue | $3,058,395,000.00 | ★ $3,094,001,000.00 |
| Revenue This Year | N/A | $13.35 |
| Revenue Next Year | N/A | $9.06 |
| P/E Ratio | ★ N/A | $22.17 |
| Revenue Growth | N/A | ★ 12.39 |
| 52 Week Low | $44.10 | $50.76 |
| 52 Week High | $105.14 | $73.51 |
Technical Indicators
Market Signals| Indicator | ARE | BMRN |
|---|---|---|
| Relative Strength Index (RSI) | 46.37 | 60.46 |
| Support Level | $47.64 | $58.44 |
| Resistance Level | $50.08 | $60.58 |
| Average True Range (ATR) | 1.15 | 1.96 |
| MACD | 0.72 | 0.39 |
| Stochastic Oscillator | 79.82 | 64.63 |
Price Performance
Historical ComparisonAbout ARE Alexandria Real Estate Equities Inc.
Alexandria Real Estate Equities Inc is an urban office real estate investment trust (REIT). It is engaged in the business of providing space for lease to life science, agtech, and technology tenants. The company has established a market presence in key locations, including Greater Boston, the San Francisco Bay Area, New York City, San Diego, Seattle, Maryland, and Research Triangle, Texas, and Canada. The Company is a life science real estate investment trust focused on developing, redeveloping, and operating properties that provide space for lease to tenants in the life science industry.
About BMRN BioMarin Pharmaceutical Inc.
BioMarin is a global biotechnology company focused on developing and commercializing therapies for rare genetic diseases. BioMarin specializes in enzyme replacement therapies, gene therapies, and other advanced treatments designed to address complex genetic disorders. The company has eight approved therapies for conditions including achondroplasia, phenylketonuria, hemophilia, and mucopolysaccharidosis. BioMarin has an expanding, yet relatively early-stage, pipeline of treatments in development across skeletal conditions and enzyme therapies.